INSIDER · CIK 1689575
Stueland Katherine
CHIEF EXECUTIVE OFFICER, Director at GeneDx Holdings Corp. (WGS)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.3MSold on the market
1Companies
Sep 18, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 202616:43 | Sep 16, 2026 | WGSGeneDx Holdings Corp. | CHIEF EXECUTIVE OFFICER, Director | S · Sell | $97.61 | −10,501 | 115,476 | -8% | −$1.0M | ||
| Sep 18, 202616:43 | Sep 16, 2026 | WGSGeneDx Holdings Corp. | CHIEF EXECUTIVE OFFICER, Director | M · Exercise | — | +18,750 | 125,977 | +17% | — | ||
| Sep 11, 202616:13 | Sep 9, 2026 | WGSGeneDx Holdings Corp. | CHIEF EXECUTIVE OFFICER, Director | S · Sell | $84.22 | −3,692 | 107,227 | -3% | −$311K | ||
| Sep 11, 202616:13 | Sep 9, 2026 | WGSGeneDx Holdings Corp. | CHIEF EXECUTIVE OFFICER, Director | M · Exercise | — | +6,547 | 110,919 | +6% | — |